Company PAREXEL International Corporation
Equities
US6994621075
Biotechnology & Medical Research
Managers
Managers | Title | Age | Since |
---|---|---|---|
Duncan MacDonald
CEO | Chief Executive Officer | 56 | - |
Gregory Rush
DFI | Director of Finance/CFO | 56 | - |
Amy McKee
CTO | Chief Tech/Sci/R&D Officer | 52 | 18-12-31 |
Michael Crowley
ADM | Chief Administrative Officer | - | 08-12-31 |
Jonathan Shough
CTO | Chief Tech/Sci/R&D Officer | - | 22-10-31 |
Peyton Howell
COO | Chief Operating Officer | 56 | 18-04-30 |
Investor Relations Contact | - | - | |
Corporate Officer/Principal | - | 19-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Sherilyn McCoy
CHM | Chairman | 65 | - |
Duncan MacDonald
CEO | Chief Executive Officer | 56 | - |
May Kin Ho
BRD | Director/Board Member | 71 | 15-08-25 |
Eric Liu
BRD | Director/Board Member | 47 | 21-10-31 |
William Chase
BRD | Director/Board Member | 57 | - |
John Groetelaars
BRD | Director/Board Member | 58 | 23-06-22 |
Michael Bruun
BRD | Director/Board Member | - | 23-06-22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 51,115,310 | 50,131,867 ( 98.08 %) | 0 | 98.08 % |
Company contact information
PAREXEL International Corp.
275 Grove Street Suite 101C
02466, Newton
+617 454 9300
http://www.parexel.comSector
1st Jan change | Capi. | |
---|---|---|
+1.12% | 43.84B | |
+6.77% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+6.01% | 25.53B | |
-24.92% | 18.18B | |
-3.63% | 12.29B | |
+27.16% | 12.29B | |
+7.30% | 11.15B |